Revenue
100 thousand iso4217-usd
2017 Q4 · iso4217-usd
Fundies. English
BIOCARDIA, INC.
EDGAR227 filing records in this dataset, filed from 1996-12-23 to 2026-10-19. Reported financial figures are available; chart coverage varies by period.
Latest quarter
Operating margin
-3,523%
2017 Q4 · %
Operating cash flow
-2.53 million iso4217-usd
2017 Q4 · iso4217-usd
Free cash flow
-2.55 million iso4217-usd
2017 Q4 · iso4217-usd
- Cash and cash equivalents
- 4.1 million USD Source
Exact value
4100000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 15 million shares Source
Exact value
14984323 shares
Reported share-count change
172.20% · 9.48 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
479 thousand iso4217-usd
2017-01-01 – 2017-12-31
Exact inputs and evidence
- Revenue: 137000 iso4217-usd · 2017-01-01 – 2017-03-31 Source
- Revenue: 112000 iso4217-usd · 2017-04-01 – 2017-06-30 Source
- Revenue: 130000 iso4217-usd · 2017-07-01 – 2017-09-30 Source
- Revenue: 479000 iso4217-usd · 2017-01-01 – 2017-12-31 Source
- Revenue: 379000 iso4217-usd · 2017-01-01 – 2017-09-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-19.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 3 of 11 periods available· newest 2017-12-31
- Operating income: 7 of 11 periods available· newest 2025-12-31
- Net income: 7 of 11 periods available· newest 2025-12-31
- Operating cash flow: 7 of 11 periods available· newest 2025-12-31
- Capital expenditure: 6 of 11 periods available· newest 2025-12-31
- Total assets: 7 of 11 periods available· newest 2025-12-31
- Total liabilities: 7 of 11 periods available· newest 2025-12-31
- Current assets: 6 of 11 periods available· newest 2025-12-31
- Current liabilities: 6 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 7 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 282,000Prior period
−USD 7.95 million
–
Current period
−USD 8.23 million
–
Exact inputs and evidence
-8228000 − -7946000 = -282000 USD
-7946000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-8228000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 450,000Prior period
−USD 7.89 million
–
Current period
−USD 7.44 million
–
Exact inputs and evidence
-7436000 − -7886000 = 450000 USD
-7886000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-7436000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+16.7%Prior period
USD 6,000
–
Current period
USD 7,000
–
Exact inputs and evidence
7000 − 6000 = 1000 USD
6000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source7000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2017 2017-01-01 – 2017-12-31
- Revenue iso4217-usd 479,000 100% of revenue
- Operating costs Derived Unavailable An input is unavailable.
- Operating income Unavailable An input is unavailable.
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income Unavailable An input is unavailable.
Cash
- Operating cash flow Unavailable An input is unavailable.
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2015 Not shown: operating income or net income is not reported.
- 2016 Not shown: operating income or net income is not reported.
- 2017 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | 904000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
| 2016 2016-01-01 – 2016-12-31 | 576000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 479000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
Amounts are exact, in iso4217-usd.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
iso4217-usd 479K 2017
Values and sources
| Period | Series | Value(iso4217-usd) | Source evidence |
|---|---|---|---|
| 2015 | Revenue | 904000 |
|
| 2016 | Revenue | 576000 |
|
| 2017 | Revenue | 479000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
-16.8% 2017
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Year over year | No prior comparable period |
|
| 2016 | Year over year | -36.3% |
|
| 2017 | Year over year | -16.8% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Operating margin | Not reported |
|
| 2016-12-31 | Operating margin | Not reported |
|
| 2017-12-31 | Operating margin | Not reported |
|
| 2015-12-31 | Net margin | Not reported |
|
| 2016-12-31 | Net margin | Not reported |
|
| 2017-12-31 | Net margin | Not reported |
|
| 2015 | Free cash flow margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(iso4217-usd) | Source evidence |
|---|---|---|---|
| 2015 | Operating cash flow | Not reported | No source recorded |
| 2016 | Operating cash flow | Not reported | No source recorded |
| 2017 | Operating cash flow | Not reported | No source recorded |
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Free cash flow | Unavailable | No source recorded |
| 2016 | Free cash flow | Unavailable | No source recorded |
| 2017 | Free cash flow | Unavailable | No source recorded |
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2016-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2017-12-31 | Liabilities / assets | Not reported | No source recorded |
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2016-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2017-12-31 | Current assets / current liabilities | Not reported | No source recorded |
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | USD 322,000 Exact valueExact value: 322000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 331,000 Exact valueExact value: 331000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 15 million Exact valueExact value: -15004000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.36 million Exact valueExact value: -12357000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 32,000 Exact valueExact value: 32000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.39 million Calculation and evidence-12357000 − 32000 USD Exact free cash flow: -12389000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 12.62 million Exact valueExact value: -12623000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10.37 million Exact valueExact value: -10366000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 116,000 Exact valueExact value: 116000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10.48 million Calculation and evidence-10366000 − 116000 USD Exact free cash flow: -10482000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 11.91 million Exact valueExact value: -11907000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10.56 million Exact valueExact value: -10561000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 70,000 Exact valueExact value: 70000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10.63 million Calculation and evidence-10561000 − 70000 USD Exact free cash flow: -10631000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 11.57 million Exact valueExact value: -11571000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.97 million Exact valueExact value: -9974000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 12,000 Exact valueExact value: 12000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.99 million Calculation and evidence-9974000 − 12000 USD Exact free cash flow: -9986000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 7.95 million Exact valueExact value: -7946000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.89 million Exact valueExact value: -7886000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6,000 Exact valueExact value: 6000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.89 million Calculation and evidence-7886000 − 6000 USD Exact free cash flow: -7892000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 8.23 million Exact valueExact value: -8228000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.44 million Exact valueExact value: -7436000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7,000 Exact valueExact value: 7000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.44 million Calculation and evidence-7436000 − 7000 USD Exact free cash flow: -7443000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
227 filings · 3,528 latest values · 3,528 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000925741, 925741, BCDA, bcda, edgar:925741
Also known as BIOCARDIA, INC., BIOCARDIA, Inc, BIOCARDIA, Inc., BioCardia, Inc, BioCardia, Inc., CLICKNSETTLE COM INC, Cardo Medical, Inc., NAM CORP, Tiger X Medical, Inc.